New York Mets (68-60, second in the NL East) vs. Atlanta Braves (58-70, fourth in the NL East) Atlanta; Saturday, 7:15 p.m. EDT PITCHING PROBABLES: Mets: Clay Holmes (10-6, 3.64 ERA, 1.34 WHIP, 105 ...

George Lopez, Jesse Garcia and Al Madrigal are among the new additions to the one-night-only virtual table read of the 2007 ...

BOTTOM LINE: The Atlanta Braves open a three-game series at home against the New York Mets on Friday. Atlanta has a 32-31 ...

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

Wegovy is now the second medicine approved in the U.S. for a disease that affects millions. Novo Nordisk has several other factors working in its favor, including strong results and a solid pipeline.

"Madrigal wins European MASH approval as Novo rivalry looms" was originally created and published by Pharmaceutical ...

PITCHING PROBABLES: Mets: David Peterson (7-5, 3.30 ERA, 1.28 WHIP, 117 strikeouts); Nationals: Jake Irvin (8-7, 5.14 ERA, 1.38 WHIP, 94 strikeouts) ...

Ella Swingle, Josie Checho, and Lucy Ritzco won singles matches in straight sets to lead Valley View to a 5-0 win over Western Wayne on Monday in a Lackawanna League girls tennis match. Valley View’s ...

EXCLUSIVE: All Things Comedy, the comedy podcast network and production company founded by Bill Burr and Al Madrigal, has ...

Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

The FDA has approved Wegovy for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis ...

With a new endorsement from the FDA, Novo Nordisk’s Wegovy has picked up its third indication and become the second drug ...